Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Notes Payables (2023 - 2026)

Cannabis Bioscience International Holdings' Notes Payables history spans 4 years, with the latest figure at $111721.0 for Q1 2026.

  • On a quarterly basis, Notes Payables changed N/A to $111721.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $111721.0, a N/A change, with the full-year FY2025 number at $9182.0, changed N/A from a year prior.
  • Notes Payables hit $111721.0 in Q1 2026 for Cannabis Bioscience International Holdings, up from $101.0 in the prior quarter.
  • Over the last five years, Notes Payables for CBIH hit a ceiling of $151267.0 in Q4 2023 and a floor of $101.0 in Q4 2025.
  • Historically, Notes Payables has averaged $57821.2 across 4 years, with a median of $9182.0 in 2025.
  • Biggest five-year swings in Notes Payables: plummeted 98.52% in 2024 and later tumbled 94.35% in 2025.
  • Tracing CBIH's Notes Payables over 4 years: stood at $151267.0 in 2023, then plummeted by 98.52% to $2236.0 in 2024, then tumbled by 95.48% to $101.0 in 2025, then soared by 110514.85% to $111721.0 in 2026.
  • Business Quant data shows Notes Payables for CBIH at $111721.0 in Q1 2026, $101.0 in Q4 2025, and $6363.0 in Q3 2025.